Emerging Challenges in Multi-Scale Modeling in Biology
Document Actions
VPHOP at Europe for Patients
Marco Viceconti, coordinator of the VPHOP integrated project, gave an invited talk at the “Europe for patients” conference, organised at the Institut Pasteur in Paris. Dr. Viceconti described the prospective that VPHOP research and technological develop is likely to open for patients affected by osteoporosis.
The French Government, as part of its semester of European Presidency, organised on October 13-14 2008 at the Institut Pasteur in Paris, an international Conference entitled “Europe for patients” aimed to underline Europe’s added value concerning questions of health, and to confront the progress that has been made concerning patients’ expectations and future issues at stake. In a session devoted to Perspectives of evolution through European multi-annual programmes of research, innovation and development in health Marco Viceconti presented the VPHOP integrated projects and drafted a scenario of what biomedical technology will become in the era of the Virtual Physiological Human.
Additional information
- VPHOP is a Collaborative Integrated Project that is developing simulation-based technology to predict the risk of bone fracture in osteoporosis patients. Co-funded by the European Commission as part of the Seventh Framework Program. The project runs for four years starting from September 2008. Coordinated by Rizzoli Orthopaedic Institute, the Project Consortium gathers 19 European Organisations based in Italy, The Netherlands, Germany, Switzerland, Belgium, France, United Kingdom, Sweden, and Iceland. For more information: http://www.vphop.eu.
- Rizzoli Orthopaedic Institute is the most famous Italian research hospital for musculoskeletal diseases. Located in Bologna, Rizzoli is a public institution, funded by the Emilia Romagna region and the Italian Ministry of Welfare. The excellent clinical units, where more than 150,000 patients are treated every year, are well integrated with nine internationally recognised research laboratories. Over 250 researchers trained as engineers, biologists, physicists, and medical doctors conduct strongly interdisciplinary research on musculoskeletal diseases, with particular attention to the transfer of results to the clinical practice. For more information: http://www.ior.it/.
- Marco Viceconti is the coordinator of the VPHOP integrated project, a large European research consortium that is developing simulation-based technology for predicting the risk of bone fracture in osteoporosis patients. Since 1989 he works at the Rizzoli Orthopaedic Institute where he is currently the Technical Director of the Medical Technology Lab. He is also the Director of the BioComputing Competence Centre. For more information: http://www.ior.it/tecno/.
Useful links